Tyra Biosciences (TYRA) Other Accumulated Expenses (2020 - 2026)
Quarterly Other Accumulated Expenses rose 33.62% to $15.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $15.1 million through Mar 2026, up 33.62% year-over-year, with the annual reading at $16.4 million for FY2025, 20.98% up from the prior year.
Tyra Biosciences filings provide 7 years of Other Accumulated Expenses readings, the most recent being $15.1 million for Q1 2026.
- Other Accumulated Expenses hit $15.1 million in Q1 2026 for Tyra Biosciences, down from $16.4 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $16.4 million in Q4 2025 and bottomed at $2.3 million in Q1 2023.
- Average Other Accumulated Expenses over 5 years is $8.4 million, with a median of $8.4 million recorded in 2024.
- Peak annual rise in Other Accumulated Expenses hit 194.11% in 2023, while the deepest fall reached 34.09% in 2023.
- Tyra Biosciences' Other Accumulated Expenses stood at $4.4 million in 2022, then skyrocketed by 135.3% to $10.4 million in 2023, then surged by 30.81% to $13.6 million in 2024, then rose by 20.98% to $16.4 million in 2025, then decreased by 8.02% to $15.1 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Other Accumulated Expenses are $15.1 million (Q1 2026), $16.4 million (Q4 2025), and $13.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.13 Mn |
| Dec 31, 2025 | 16.44 Mn |
| Sep 30, 2025 | 13.43 Mn |
| Jun 30, 2025 | 11.08 Mn |
| Mar 31, 2025 | 11.32 Mn |
| Dec 31, 2024 | 13.59 Mn |
| Sep 30, 2024 | 10.81 Mn |
| Jun 30, 2024 | 8.42 Mn |
| Mar 31, 2024 | 5.47 Mn |
| Dec 31, 2023 | 10.39 Mn |
| Sep 30, 2023 | 7.69 Mn |
| Jun 30, 2023 | 3.82 Mn |
| Mar 31, 2023 | 2.26 Mn |
| Dec 31, 2022 | 4.42 Mn |
| Sep 30, 2022 | 2.62 Mn |
| Jun 30, 2022 | 2.99 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 2.57 Mn |
| Dec 31, 2020 | 1.05 Mn |